Medytox Venture Investment was more active than Medytox itself, holding consultations with 17 technology suppliers. Among the 17, those in the pharmaceutical and bio industry sector included 10 companies: Dr. Noah Biotech, Rosetta Exosome, RudaCure, Medical Innovation Developer, Brexogen, Endo Robotics, Organ Factory, Pharmacorex, ProAptec, and FieldCure.
The university sector included industry-academia cooperation foundations and technology holding companies from 6 universities: Catholic University, Gwangju Institute of Science and Technology (GIST), Kookmin University, Dankook University, Seoul National University, and Yonsei University. Consultations were also held with the Korea Research Institute of Bioscience and Biotechnology, which had the busiest schedule among all individual technology suppliers during the event.
If this year was Medytox, the most active acquirer at the previous year's InterBiz 2019 had been Hugel, which held consultations with 28 technology suppliers from diverse stakeholder groups including Seoul National University, Yonsei University Medical Center, Y&D Life Science, and the Korea Research Institute of Chemical Technology.